MiniMed Group Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, MiniMed Group stock has a consensus rating of "Buy" and an average price target of $24.83. The average 1-year stock price forecast is 6.64% higher than the current stock price, while the lowest is $15 (-35.58%) and the highest is $28 (+20.25%).

Price Target: $24.83 (+6.64%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$15	$24.83	$26	$28
Change	-35.58%	+6.64%	+11.66%	+20.25%

Analyst Ratings

The average analyst rating for MiniMed Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	9	10	10	10	10	10
Buy	2	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steven Lichtman William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Sep 2, 2026
Pito Chickering Deutsche Bank	Deutsche Bank	Buy Reiterates $20 → $25	Buy	Reiterates	$20 → $25	+7.37%	Sep 2, 2026
Daniel Markowitz CFA Evercore ISI	Evercore ISI	Buy Maintains $20 → $27	Buy	Maintains	$20 → $27	+15.95%	Sep 2, 2026
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Buy Reiterates $21 → $19	Buy	Reiterates	$21 → $19	-18.40%	Sep 2, 2026
Anthony Petrone Mizuho Securities	Mizuho Securities	Buy Maintains $21 → $26	Buy	Maintains	$21 → $26	+11.66%	Sep 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.44B

from 3.10B

10.80%

from 3.10B

Revenue Next Year

3.72B

from 3.44B

8.24%

from 3.44B

EPS This Year

0.68

from -0.56

EPS Next Year

0.65

from 0.68

-4.94%

from 0.68

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 28, 2023	Apr 26, 2024	Apr 25, 2025	Apr 24, 2026	Apr 30, 2027
Revenue	2.25B	2.47B	2.72B	3.10B	3.44B
Revenue Growth	-	9.98%	9.96%	14.25%	10.80%
Gross Profit	1.32B	1.44B	1.53B	1.77B	1.94B
Gross Margin	58.62%	58.24%	56.28%	57.06%	56.42%
Operating Income	-61.00M	-53.00M	33.00M	122.00M	235.45M
Net Income	-96.00M	-112.00M	-213.00M	-333.00M	180.79M
EPS	-	-	-	-0.56	0.68
Forward PE	-	-	-	43.29	34.09
Free Cash Flow	-	-71.13M	114.63M	-71.75M	-447.90M
No. Analysts	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	3.5B
Avg	3.4B
Low	3.4B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	11.9%
Avg	10.8%
Low	10.4%

EPS Forecast

Chart

EPS	2027	2028	2029
High	0.75
Avg	0.68
Low	0.62

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-